Brain-derived neurotrophic factor gene variants and obesity in former smokers

被引:2
|
作者
Yang, Shan-shan [1 ,2 ]
He, Yao [1 ]
Xu, Lin [3 ,4 ]
Jin, Yali [5 ]
Zhang, Wei-sen [5 ]
Jiang, Chao-qiang [5 ]
Cheng, Kar Keung [6 ]
Lam, Tai Hing [1 ,4 ,5 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 2, Natl Clin Res Ctr Geriatr Dis, Beijing Key Lab Aging & Geriatr,Inst Geriatr, 28 Fuxing Rd, Beijing 100853, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Dis Prevent & Control, 28 Fuxing Rd, Beijing 100853, Peoples R China
[3] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China
[4] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Peoples R China
[5] Guangzhou 12 Peoples Hosp, Guangzhou, Peoples R China
[6] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England
基金
中国国家自然科学基金;
关键词
Obesity; Central obesity; Smoking cessation; BDNF; VITAMIN-D DEFICIENCY; WEIGHT-GAIN; SMOKING; MORTALITY; CHINA; ASSOCIATION; PREVALENCE; FRAILTY; RISK; MEN;
D O I
10.1186/s12864-021-07928-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objective From genome-wide association studies, brain-derived neurotrophic factor (BDNF) locus on chromosome 11 was the only SNP associated with both smoking and body mass index (BMI) in European, African and Asian population. This study aims to explore the unique genetic predisposition to obesity in former smokers by examining the effects of BDNF on BMI and waist circumference (WC). Methods The study design is case-control study with a cohort validation in supplementary. We included 15,072 ethnic Chinese participants in the Guangzhou Biobank Cohort Study (GBCS) with data of four BDNF SNPs related to both BMI and smoking behavior. We used baseline smoke exposure data in 2003-2007 and follow-up outcomes of general obesity (by BMI) and central obesity (WC) in 2008-2012. Odds ratios (ORs) and 95% confidence intervals (CIs) for general obesity and central obesity associated with these SNPs were derived from logistic regression. Results Of 15,072 participants (3169 men and 11,903 women), 1664 (11.0%) had general and 7868 (52.2%) had central obesity. In 1233 former smokers, the rs6265 GG, versus AA, genotype was associated with higher risks of general obesity (OR = 1.79, 95% CI = 1.06-3.01) and central obesity (OR = 2.08, 95% CI = 1.47-2.92) after adjustment. These associations were not significant in never or current smokers. In former heavy (>= 20 cigarettes/day) smokers, the rs6265 GG genotype showed a higher odds for general obesity (OR = 2.15, 95% CI = 1.05-4.40), while no association was found in former light (1-9 cigarettes/day) smokers. Similar results were found for the association of rs6265 with central obesity and for the associations of other two BDNF SNPs (rs4923457 and rs11030104) with both general and central obesity. Conclusions We firstly identified the genetic predisposition (BDNF SNPs) to general and central obesity in former smokers, particularly in former heavy smokers. The different associations of the SNPs for general/central obesity in different smoke exposure groups may be related to the competitive performance of the sites and epigenetic modification, which needs further study.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] The Impact of the Brain-Derived Neurotrophic Factor Gene on Trauma and Spatial Processing
    Miller, Jessica K.
    McDougall, Sine
    Thomas, Sarah
    Wiener, Jan
    JOURNAL OF CLINICAL MEDICINE, 2017, 6 (12)
  • [42] Brain-derived neurotrophic factor gene polymorphisms and Alzheimer's disease
    Matsushita, S
    Arai, H
    Matsui, T
    Yuzuriha, T
    Urakami, K
    Masaki, T
    Higuchi, S
    JOURNAL OF NEURAL TRANSMISSION, 2005, 112 (05) : 703 - 711
  • [43] Brain-Derived Neurotrophic Factor and Ciliary Neurotrophic Factor in Patients with Depression
    Shpak, A. A.
    Guekht, A. B.
    Druzhkova, T. A.
    Zinchuk, M. S.
    Gulyaeva, N. V.
    NEUROCHEMICAL JOURNAL, 2020, 14 (02) : 239 - 242
  • [44] Brain-Derived Neurotrophic Factor and Ciliary Neurotrophic Factor in Patients with Depression
    A. A. Shpak
    A. B. Guekht
    T. A. Druzhkova
    M. S. Zinchuk
    N. V. Gulyaeva
    Neurochemical Journal, 2020, 14 : 239 - 242
  • [45] Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene
    Rybakowski, JK
    Suwalska, A
    Skibinska, M
    Szczepankiewicz, A
    Leszczynska-Rodziewicz, A
    Permoda, A
    Czerski, PM
    Hauser, J
    PHARMACOPSYCHIATRY, 2005, 38 (04) : 166 - 170
  • [46] The brain-derived neurotrophic factor gene in chronic tinnitus: A pilot investigation
    Sand, P.
    Kleinjung, T.
    Langguth, B.
    Eichhammer, P.
    Fischer, B.
    Pratt, C.
    Pfluegl, S.
    Niebling, H.
    Hajak, G.
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2006, 24 (08) : 506 - 506
  • [47] Association study of brain-derived neurotrophic factor gene polymorphism and alcoholism
    Matsushita, S
    Kimura, M
    Miyakawa, T
    Yoshino, A
    Murayama, M
    Masaki, T
    Higuchi, S
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (11) : 1609 - 1612
  • [48] MECHANISM OF HYPERPHAGIA CONTRIBUTING TO OBESITY IN BRAIN-DERIVED NEUROTROPHIC FACTOR KNOCKOUT MICE
    Fox, E. A.
    Biddinger, J. E.
    Jones, K. R.
    McAdams, J.
    Worman, A.
    NEUROSCIENCE, 2013, 229 : 176 - 199
  • [49] Opposite changes in the serum brain-derived neurotrophic factor in anorexia nervosa and obesity
    Monteleone, P
    Tortorella, A
    Martiadis, V
    Serritella, C
    Fuschino, A
    Maj, M
    PSYCHOSOMATIC MEDICINE, 2004, 66 (05): : 744 - 748
  • [50] Brain-derived neurotrophic factor for gene therapy of peripheral nerve trauma
    Semina, E.
    Rubina, K.
    Sysoeva, V.
    Karyagyaur, M.
    Stambolsky, D.
    Kalinina, N.
    Tkachuk, V.
    HUMAN GENE THERAPY, 2011, 22 (10) : A92 - A93